Back to top
more

AbbVie (ABBV)

(Real Time Quote from BATS)

$201.52 USD

201.52
1,465,839

+1.05 (0.52%)

Updated Nov 5, 2024 12:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Large Cap Pharmaceuticals

Zacks News

Zacks Value Trader Highlights: AbbVie, B&G Foods, H&R Block, Microsoft and Apple

Zacks Value Trader Highlights: AbbVie, B&G Foods, H&R Block, Microsoft and Apple

Is AbbVie (ABBV) Stock a Solid Choice Right Now?

AbbVie (ABBV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Top Ranked Income Stocks to Buy for May 22nd

Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 22nd.

Tracey Ryniec headshot

This Book Changed Warren Buffett's Life

With the coronavirus crisis throwing investors for a loop, it's time to consult with the father of value investing, Benjamin Graham.

Simple Secrets Anyone Can Use to Reach Early Retirement - May 21, 2020

Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.

3 Top Dividend Stocks to Maximize Your Retirement Income - May 20, 2020

The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Dr. Reddy's (RDY) Q4 Earnings Increase Y/Y, Revenues Beat

Dr. Reddy's (RDY) fourth-quarter earnings and sales increase year over year.

AbbVie, Interactive, Inphi, Chegg and ServiceNow highlighted as Zacks Bull and Bear of the Day

AbbVie, Interactive, Inphi, Chegg and ServiceNow highlighted as Zacks Bull and Bear of the Day

3 Value Stocks That Could Thrive in a Post-Pandemic World

With an economic revival in motion despite the unfavorable circumstances so far, value stocks offer the much-needed stability to one's portfolio.

J&J to Stop Sale of Talc-Based Baby Powder in North America

J&J (JNJ) faces thousands of lawsuits, which claim that its talc-based products, primarily its baby powders, cause cancer.

David Borun headshot

Bull of the Day: AbbVie (ABBV)

With profitable products on the market and a powerful pipeline, AbbVie is a defensive stock with growth potential

David Borun headshot

Bear of the Day: InterActive Corp (IAC)

This already high-priced stock has become even more expensive after a huge recovery rally.

Top Ranked Value Stocks to Buy for May 20th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 20th

AbbVie (ABBV) Upgraded to Strong Buy: Here's What You Should Know

AbbVie (ABBV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?

Is (ABBV) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For May 19th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Is AbbVie (ABBV) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Extreme Risks of Trading Your Own Retirement Assets - May 18, 2020

Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.

The Zacks Analyst Blog Highlights: JPMorgan Chase, AbbVie, Royal Dutch Shell, Gilead Sciences and Anthem

The Zacks Analyst Blog Highlights: JPMorgan Chase, AbbVie, Royal Dutch Shell, Gilead Sciences and Anthem

Kinjel Shah headshot

Pharma Stock Roundup: FDA Updates for LLY, AZN, MRK, BMY and SNY

FDA approves Lilly's (LLY) selpercatinib for RET-altered lung and thyroid cancers and AstraZeneca (AZN)/Merck's (MRK) Lynparza for new ovarian cancer use.

Sheraz Mian headshot

Top Stock Reports for JPMorgan, AbbVie & Royal Dutch Shell

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), AbbVie (ABBV) and Royal Dutch Shell (RDS.A).

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - May 14, 2020

The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Powerful Proof Anyone Can Invest for an Early Retirement - May 13, 2020

Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.

Reata (RETA) Q1 Earnings Surpass Estimates, Revenues Miss

Reata (RETA) reports narrower-than-expected loss but misses revenue estimates for first-quarter 2020. Shares down.